Burrard Pharmaceuticals

burrardpharma.com

Burrard Pharmaceuticals is an international leading biopharmaceutical company. We have access to modern state-of-the-art pharmaceutical facilities. The operational efficiency of our facility results in diverse production options, reduced lifecycle costs and compliance to all pharma GMP regulations. We have extensive expert resources combining unique processes and full technology integration. Since our founding in 2005, we are at the forefront of drug manufacturing and technology transfer.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Business Insights

C-PATH AND REPLICA ANALYTICS COLLABORATION AIMS TO ACCELERATE RARE DISEASE RESEARCH

Replica Analytics | June 30, 2022

news image

Critical Path Institute and Replica Analytics, an Aetion company, announced a new partnership that involves leveraging synthetic data to further catalyze the generation of actionable solutions to accelerate drug development for rare diseases. Replica Analytics will help generate synthetic datasets across rare and orphan indications in which patient-level datasets are often quite small, which heightens considerations regarding data privacy and accessibility. Together...

Read More

Business Insights, PHARMACY MARKET

TETRIS PHARMA SIGNS SERVICE AGREEMENT WITH SYNEOS HEALTH

Tetris Pharma Ltd | December 13, 2022

news image

Tetris Pharma Ltd a subsidiary of biopharmaceutical company, Arecor Therapeutics plc announces that it has signed a service agreement with Syneos Health® the only fully integrated biopharmaceutical solutions organization purpose-built to accelerate customer success, to support the build out of Tetris Pharma’s commercial platform across Europe. Through this partnership, Syneos Health will provide commercial support through an outsourced contract sales services to accelera...

Read More

Business Insights

LIFESPIN LAUNCHES COMMERCIAL ACCESS TO ITS METABOLIC PROFILER SOFTWARE AND DATABASE FOR PHARMA AND BIOBANK SERVICES

Lifespin | September 16, 2022

news image

Lifespin GmbH, based in Regensburg with offices in Boston, Massachusetts, announced that it has launched a new commercial service that, for the first time, will provide the pharmaceutical and biobanking industry with access to Lifespin’s proprietary metabolic database, along with its advanced interpretive software to assist in various phases of drug research, development, and manufacturing. Immediate applications of Lifespin’s commercial services will include quality c...

Read More

PHARMA SEES MORE POST-M&A REBRANDS THAN OTHER INDUSTRIES—AND IT DOES THEM BETTER, TOO

Fiercepharma | June 03, 2020

news image

To rebrand or not? It’s a big question for pharma companies before and after acquisitions—and one answered with "yes" more often than in other industries. Pharma, in fact, was the most prolific rebrander in Brand Finance’s recent research assessing the value of rebrands across 25 industries. It's also one of the most successful, with rebrands in pharma generating average returns of 13.8%, according to Brand Finance calculations. The main reason? Most acquired phar...

Read More
news image

Business Insights

C-PATH AND REPLICA ANALYTICS COLLABORATION AIMS TO ACCELERATE RARE DISEASE RESEARCH

Replica Analytics | June 30, 2022

Critical Path Institute and Replica Analytics, an Aetion company, announced a new partnership that involves leveraging synthetic data to further catalyze the generation of actionable solutions to accelerate drug development for rare diseases. Replica Analytics will help generate synthetic datasets across rare and orphan indications in which patient-level datasets are often quite small, which heightens considerations regarding data privacy and accessibility. Together...

Read More
news image

Business Insights, PHARMACY MARKET

TETRIS PHARMA SIGNS SERVICE AGREEMENT WITH SYNEOS HEALTH

Tetris Pharma Ltd | December 13, 2022

Tetris Pharma Ltd a subsidiary of biopharmaceutical company, Arecor Therapeutics plc announces that it has signed a service agreement with Syneos Health® the only fully integrated biopharmaceutical solutions organization purpose-built to accelerate customer success, to support the build out of Tetris Pharma’s commercial platform across Europe. Through this partnership, Syneos Health will provide commercial support through an outsourced contract sales services to accelera...

Read More
news image

Business Insights

LIFESPIN LAUNCHES COMMERCIAL ACCESS TO ITS METABOLIC PROFILER SOFTWARE AND DATABASE FOR PHARMA AND BIOBANK SERVICES

Lifespin | September 16, 2022

Lifespin GmbH, based in Regensburg with offices in Boston, Massachusetts, announced that it has launched a new commercial service that, for the first time, will provide the pharmaceutical and biobanking industry with access to Lifespin’s proprietary metabolic database, along with its advanced interpretive software to assist in various phases of drug research, development, and manufacturing. Immediate applications of Lifespin’s commercial services will include quality c...

Read More
news image

PHARMA SEES MORE POST-M&A REBRANDS THAN OTHER INDUSTRIES—AND IT DOES THEM BETTER, TOO

Fiercepharma | June 03, 2020

To rebrand or not? It’s a big question for pharma companies before and after acquisitions—and one answered with "yes" more often than in other industries. Pharma, in fact, was the most prolific rebrander in Brand Finance’s recent research assessing the value of rebrands across 25 industries. It's also one of the most successful, with rebrands in pharma generating average returns of 13.8%, according to Brand Finance calculations. The main reason? Most acquired phar...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us